Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.90%
1,049.94
+19.54
+1.90%
1,030.401,038.581,051.411,035.31
SIXC
Communications
SIXC
Communications
SIXC
+0.55%
584.74
+3.19
+0.55%
581.55581.55588.95580.07
SIXE
Energy
SIXE
Energy
SIXE
-0.21%
1,277.84
-2.67
-0.21%
1,280.511,276.071,284.111,270.93
SIXI
Industrials
SIXI
Industrials
SIXI
+0.93%
1,670.25
+15.36
+0.93%
1,654.891,661.281,676.931,658.69
SIXM
Financials
SIXM
Financials
SIXM
+0.27%
609.84
+1.63
+0.27%
608.21610.01616.39604.82
SIXR
Staples
SIXR
Staples
SIXR
+0.48%
825.36
+3.92
+0.48%
821.44825.11825.75814.89
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.50%
199.39
+1.00
+0.50%
198.39198.39199.86197.46
SIXT
Technology
SIXT
Technology
SIXT
+0.69%
2,762.43
+18.84
+0.69%
2,743.592,763.922,779.962,746.33
SIXU
Utilities
SIXU
Utilities
SIXU
+1.09%
924.18
+10.00
+1.09%
914.18917.51924.94917.14
SIXV
Health care
SIXV
Health care
SIXV
+1.08%
1,481.18
+15.79
+1.08%
1,465.391,470.631,483.871,470.63
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.17%
2,243.52
+25.86
+1.17%
2,217.662,241.932,262.302,226.34
BOI:EPA
Boiron SA
€25.60
+2.40%
(+0.60) 1D
Mar 25, 5:35:12 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BOI...
Open
€25.00
High
€26.70
Low
€24.35
Mkt. cap
449.16M
Avg. vol.
1.18K
Volume
2.47K
P/E ratio
22.95
52-wk high
€32.25
52-wk low
€20.85
EPS
€1.12
Shares outstanding
17.55M
No. of employees
3K
News stories
From sources across the web
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2.74K
FoundedJun 7, 1932
Headquarters-
SectorPharmaceutical industry
Websiteboiron.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
129.61M
129.61M
122.82M
122.82M
Cost of goods sold
34.07M
34.07M
32.29M
32.29M
Cost of revenue
34.07M
34.07M
32.29M
32.29M
Research and development expenses
1.60M
1.60M
1.27M
1.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
76.90M
76.90M
79.15M
79.15M
Operating expense
80.92M
80.92M
79.55M
79.55M
Total operating expenses
114.99M
114.99M
111.85M
111.85M
Operating income
14.62M
14.62M
10.98M
10.98M
Other non operating income
-2.48M
-2.48M
-3.01M
-3.01M
EBT including unusual items
5.06M
5.06M
7.61M
7.61M
EBT excluding unusual items
13.33M
13.33M
7.60M
7.60M
Income tax expense
1.06M
1.06M
1.93M
1.93M
Effective tax rate
20.94%
20.94%
25.37%
25.37%
Other operating expenses
2.42M
2.42M
-864.50K
-864.50K
Net income
4.00M
4.00M
5.68M
5.68M
Net profit margin
3.09%
3.09%
4.63%
4.63%
Earnings per share
-
-
-
-
Interest and investment income
830.00K
830.00K
613.50K
613.50K
Interest expense
-279.50K
-279.50K
-220.50K
-220.50K
Net interest expenses
550.50K
550.50K
393.00K
393.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
19.02M
19.02M
16.52M
16.52M
Gain or loss from assets sale
8.50K
8.50K
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more